Data as of 3:59pm ET
| -0.47 / -2.80%|
The 2 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 20.50, with a high estimate of 22.00 and a low estimate of 19.00. The median estimate represents a +25.54% increase from the last price of 16.33.
The current consensus among 3 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.